PT  - JOURNAL ARTICLE
AU  - van der Toorn, Wiep
AU  - Oh, Djin-Ye
AU  - Bourquain, Daniel
AU  - Michel, Janine
AU  - Krause, Eva
AU  - Nitsche, Andreas
AU  - Kleist, Max von
AU - on behalf of the working group on SARS-CoV-2 Diagnostics at RKI
TI  - COVIDStrategyCalculator: A standalone software to assess testing- and quarantine strategies for incoming travelers, contact person management and de-isolation
AID  - 10.1101/2020.11.18.20233825
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.11.18.20233825
4099  - http://medrxiv.org/content/early/2020/11/18/2020.11.18.20233825.short
4100  - http://medrxiv.org/content/early/2020/11/18/2020.11.18.20233825.full
AB  - In early 2020 COVID-19 turned into a global pandemic. Non-pharmaceutical interventions (NPIs), including the isolation of infected individuals, tracing and quarantine of exposed individuals are decisive tools to prevent onwards transmission and curb fatalities. Strategies that combine NPIs with SARS-CoV-2 testing may help to shorten quarantine durations while being non-inferior with respect to infection prevention. Thus, combined strategies can help reducing the socio-economic burden of SARS-CoV2 and generate greater public acceptance. We developed a software that enables policy makers to calculate the reduction in transmissibility through quarantine or isolation in combination with arbitrary testing strategies. The user chooses between three different modi [(i) isolation of infected individuals, (ii) management of potentially infected contacts and (iii) quarantine of incoming travelers], while having total flexibility in customizing testing strategies, as well as setting model parameters. The software enables decision makers to tailor calculations specifically to their questions and perform an assessment ‘on the fly’, based on current evidence on infection dynamics.Underneath, we analytically solve a stochastic transit compartment model of the infection time course, which captures temporal changes in test sensitivities, incubation- and infectious periods, as well as times to symptom onset using its default parameters.Using default parameters, we estimated that testing travelers at the point of entry reduces the risk about 4.69 (4.19,4.83) fold for PCR vs. 3.59 (3.22, 3.69) fold for based rapid diagnostic tests (RDT, 87% relative sensitivity) when combined with symptom screening. In comparison to 14 days of pure quarantine, 8 (PCR) vs. 10 (RDT) days of pre-test quarantine would be noninferior for incoming travelers as well as for contact person management. De-isolation of infected individuals 11 days after symptom onset reduces the risk by >99fold (7.68,>1012).This tool is freely available from: https://github.com/CovidStrategyCalculator/CovidStrategyCalculatorCompeting Interest StatementThe authors have declared no competing interest.Funding StatementWvDT and MvK acknowledge funding from the Germany ministry for science and education (BMBF; grant numbers 01KI2016 and 031L0176A). D-YO acknowledges funding through the German ministry of health (BMG) as part of the COVID emergency crisis funds provided to RKI. The funders had no role in designing the research or the decision to publish.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data for reproducing the results is available as outlined in the manuscript. https://github.com/CovidStrategyCalculator/CovidStrategyCalculator